Report Description

India Favipiravir market is projected to show a robust growth in the forecast period, FY2023 - FY2027, with an impressive CAGR, on account of rising demand for effective and efficient drugs and therapeutics for the viral infection like COVID-19. The drug is being manufactured and marketed in large scale for its effectiveness in controlling mild to moderate COVID-19 infection. Moreover, the drug is also effective in the treatment of viral infections from Ebola virus and Influenza A & B viruses. All these advantages of Favipiravir has led to an increase in the  growth of the India Favipiravir market. Also, after the approval to new market players like Lupin, and Vivimed Ltd. the market growth is anticipated to boost in the next five years. With consistent technological advancement and governmental support towards the extensive research and development of the efficient drugs, the market is expected to register its exponential CAGR growth in the upcoming five years. Although, rapidly emerging drugs from the export pathway may put a minor restraint on the market growth in the upcoming five years.

The India Favipiravir market is segmented on the basis of route of administration, dosage form, distribution channel, application, source, regional distribution, and competitional landscape. Based on route of administration, the market is further bifurcated into oral and intravenous administrations. Intravenous administrations are the method of injecting the drug in a solution form in the veins of the patient. The method is anticipated to be more effective over oral administrations of any drug. Oral administrations involve intake of tablets. The Favipiravir drug is widely available in the tablet form in the Indian market. Major market players like Vivimed ltd. have received authority from the director general of health services in India to manufacture and market the Favipiravir tablets with the name, ‘Favulous’ of 200mg and 400mg strength. With the unexpected jump in the number of patients suffering from COVID-19, the market is experiencing a surge in the demand for more and effective treatment options.

Holding the largest shares of the India Favipiravir market, a partial list of the established market players includes Cipla Ltd., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Zendara Pharma Ltd., Indoco Remedies Ltd., Curequest Lifescience India Pvt. Ltd., Gonane Pharma Ltd., Lee Pharma Ltd., Hetero Labs Pvt. Ltd., Dr. Reddy’s Laboratories Ltd, among others. The pharmaceutical companies are in close contact with the research and development institutes that are consistently developing the better and efficient therapeutics and drugs like Favipiravir to overcome the impact of the pandemic. Technological advancement and advanced research techniques are being implemented and pharmaceutical companies are making sure that they have the approval from the governmental authorities to manufacture and market the drugs and the therapeutics on a larger scale.

Years considered for this report:

Historical Years: FY2017 – FY2020

Base Year: FY2021

Estimated Year: FY2022E

Forecast Period: FY2023F – FY2027F

Objective of the Study:

o   To analyze the historical growth in the market size of India Favipiravir market from FY2017 to FY2021.

o   To estimate and forecast the market size of India Favipiravir market from FY2022 to FY2027 and growth rate until FY2027. 

o   To classify and forecast India Favipiravir market based on route of administration, dosage form, distribution channel, application, source, competitional landscape, and regional distribution.

o   To identify dominant region or segment in the India Favipiravir market.

o   To identify drivers and challenges for India Favipiravir market.

o   To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India Favipiravir market.

o   To identify and analyze the profile of leading players operating in India Favipiravir market.

o   To identify key sustainable strategies adopted by market players in India Favipiravir market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India Favipiravir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

o   Favipiravir manufacturers, end users, and other stakeholders

o   Distributers and suppliers of Favipiravir and other stakeholders

o   Organizations, forums and alliances related to Favipiravir

o   Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India Favipiravir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Favipiravir Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Favipiravir Market, By Dosage Form:

o   Tablet

o   Capsule

  • India Favipiravir Market, By Application:
    • Influenza A&B
    • Ebola
    • COVID-19
  • India Favipiravir Market, By Source:
    • Contract Manufacturing Organizations
    • In-House
  • India Favipiravir Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Drug Stores/ Pharmacies
    • Online
    • Others
  • India Favipiravir Market, By Region:
    • South
    • West
    • North
    • East


Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Favipiravir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

o   Detailed analysis and profiling of additional market players (up to five).

India Favipiravir Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.     Product of Interest: Favipiravir Market

2.    Research Methodology

3.    Impact of COVID-19 on India Favipiravir Market

4.    Executive Summary

5.    Voice of Customers

6.    India Favipiravir Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value and By Volume

6.2.  Market Share & Forecast

6.2.1.     By Route of Administration (Oral v/s Intravenous)

6.2.2.     By Dosage Form (Tablet v/s Capsule)

6.2.3.     By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others)

6.2.4.     By Application (Influenza A&B, Ebola, COVID-19)

6.2.5.     By Source (Contract Manufacturing Organizations, In-House)

6.2.6.     By Company (FY2021)

6.3.  Product Market Map

7.    North Favipiravir Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value and By Volume

7.2.  Market Share & Forecast

7.2.1.     By Route of Administration

7.2.2.     By Dosage Form

7.2.3.     By Distribution Channel

7.2.4.     By Application

7.2.5.     By Source

8.    South India Favipiravir Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value and By Volume

8.2.  Market Share & Forecast

8.2.1.     By Route of Administration

8.2.2.     By Dosage Form

8.2.3.     By Distribution Channel

8.2.4.     By Application

8.2.5.     By Source

9.    East India Favipiravir Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value and By Volume

9.2.  Market Share & Forecast

9.2.1.     By Route of Administration

9.2.2.     By Dosage Form

9.2.3.     By Distribution Channel

9.2.4.     By Application

9.2.5.     By Source

10.  West India Favipiravir Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value and By Volume

10.2.              Market Share & Forecast

10.2.1.  By Route of Administration

10.2.2.  By Dosage Form

10.2.3.  By Distribution Channel

10.2.4.  By Application

10.2.5.  By Source

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Pricing Analysis

14.  Policy & Regulatory Landscape

15.  India Economic Profile

16.  Competitive Landscape

16.1.              Company Profiles

16.1.1.  Cipla Ltd.

16.1.2.  Glenmark Pharmaceuticals Ltd.

16.1.3.  Sun Pharmaceuticals Industries Ltd.

16.1.4.  Zendara Pharma Ltd.

16.1.5.  Indoco Remedies Ltd.

16.1.6.  Curequest Lifescience India Pvt. Ltd.

16.1.7.  Gonane Pharma Ltd.

16.1.8.  Lee Pharma Ltd.

16.1.9.  Hetero Labs Pvt. Ltd.

16.1.10. Dr. Reddy’s Laboratories Ltd.

17.  Strategic Recommendations

18. About Us & Disclaimer

Figures and Tables

Frequently asked questions